key: cord-0774398-lsyzjd98
authors: Wang, Feng; Yao, Yin; Hou, Hongyan; Wu, Shiji; Guo, Cuilian; Zhou, Hongmin; Liu, Zheng; Sun, Ziyong
title: Delayed virus‐specific antibody responses associate with COVID‐19 mortality
date: 2020-08-05
journal: Allergy
DOI: 10.1111/all.14546
sha: bea44797c7f1dab9f5ab642fe833e15383944f46
doc_id: 774398
cord_uid: lsyzjd98

nan

by the World Health Organization 1 . Recent studies observed a robust antibody response against SARS-CoV-2 in patients with COVID-19, even in those discharged patients, supporting the key role of humoral response in limiting SARS-CoV-2 infection [2] [3] [4] . However, the association of humoral response, especially antibody production, with clinical outcome of COVID-19 is still unknown.

A total of 149 COVID-19 patients, including 92 survived and 57 deceased patients from Tongji Hospital were enrolled in this study between February and April 2020. No significant difference in age, gender, clinical symptoms, and imaging features was recorded between survived and deceased patients. However, the prevalence of chronic obstructive pulmonary disease and cardiovascular disease was significantly higher in deceased patients than in survived patients (Supplementary Table 1 ). In line with previous reports 5, 6 , deceased patients demonstrated greater levels of a series of inflammatory markers, including C-reactive protein, procalcitonin, ferritin, interleukin (IL)-1, IL-2 receptor, IL-6, IL-8, IL-10, and tumor necrosis factor (TNF)- in serum compared to survived patients. In contrast, a dramatically reduced lymphocytes, including CD3 + T, CD4 + T, CD8 + T, and NK cells, were noted in deceased patients in comparison with survived

This article is protected by copyright. All rights reserved patients (Supplementary Table 2 

To explore the difference of humoral immune responses between survived and deceased patients, we first detected SARS-CoV-2-specific immunoglobulin (Ig)M and IgG levels in serum.

To our surprise, we failed to find any difference in overall levels of SARS-CoV-2-specific IgM Figure 2a , as previously described 3, 9 . In consistent with ASC response, SARS-CoV-2 infection-induced generation of cT FH cells in the early stage in deceased patients was significantly lower than that in survived patients (Figure 2b) . Based on C-X-C chemokine receptor 3 (CXCR3) and C-C motif chemokine receptor 6 (CCR6) expression, circulating T FH and non-T FH can be defined three major subsets: CXCR3 + CCR6type 1 (T FH 1 or T H 1), CXCR3 -CCR6type 2 (T FH 2 or T H 2), and CXCR3 -CCR6 + type 17 (T FH 17 or T H 17) cells, and T FH 1 cells have been reported to be associated with neutralizing antibody responses in influenza immunized subjects and hepatitis C virus-infected patients 10, 11 . We found that the percentage of T FH 1 cells, but not T FH 2 and T FH 17 cells, was significantly decreased in deceased patients compared with survived patients (Figure 2b) . Table 1 ). The outcomes of enrolled patients were classified as survival (discharged alive) and death. The demographic and clinical information, laboratory results and outcome data were obtained from electronic medical records. This study was approved by the ethical committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (TJ-C20200128).

The clinical samples (throat or nasal swab) obtained from patients at admission were maintained in Accepted Article

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19

Antibody responses to SARS-CoV-2 in patients with COVID-19

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals

Mild versus severe COVID-19: Laboratory markers

The laboratory tests and host immunity

Briefly, RNA was extracted from clinical samples. Five microliters of RNA was used for real-time RT-PCR, which targeted the ORF1ab and N gene. Real-time RT-PCR was performed using the following conditions: 50°C for 15 min and 95°C for 5 min, 45 cycles of amplification at 95°C for 10 s and 55°C for 45 s. The positive SARS-CoV-2 real time RT-PCR

SARS-CoV-2-specific IgM and IgG detection Serum samples were collected from patients at admission. The SARS-CoV-2-specific IgM and IgG which target the receptor-binding domain of the spike protein were detected by paramagnetic particle chemiluminescent immunoassay using iFlash-SARS-CoV-2 IgM/IgG assay kit

Cytokine analysis Serum samples were collected from patients at admission and the levels of IL-1, IL-2R, IL-8, IL-10, and TNF- in serum were measured according to an automatic procedure of a solid-phase two-site chemiluminescent immunometric assay via IMMULITE 1000 Analyzer (Siemens). The level of IL-6 was measured by electrochemiluminescence method

Cell surface staining was performed on peripheral blood mononuclear cells or whole blood cells (after lysis of erythrocytes). The viability of the cells was greater than 95% determined by trypan blue staining. Isotype controls with irrelevant specificities were included as negative controls. The cell pellets were finally analyzed with FACSCanto flow cytometer (BD Biosciences)

The authors have declared that they have no conflicts of interest.

This article is protected by copyright. All rights reserved automatic compensation settings using the FACSCanto software.TBNK lymphocyte counting. The percentages and absolute numbers of CD4 + T cells, CD8 + T cells, B cells, and NK cells were determined by using TruCOUNT tubes and BD Multitest 6-color TBNK Reagent Kit (BD Biosciences) according to the manufacturer's instructions.ASCs. The following monoclonal antibodies (mAbs) were used: anti-CD45, anti-CD19, anti-CD27, and anti-CD38 (BD Biosciences). ASCs were defined as CD19 + CD27 + CD38 + B cells. 

The results are presented as mean ± standard deviation (SD), or as median with IQR when appropriate. Continuous variables were compared with Mann-Whitney U-test. Chi-square test was used for categorical data. Spearman's rank correlation test for non-parametric data was employed to analyze the relationship between two factors. Statistical significance was determined as p < 0.05 (*p < 0.05, **p < 0.01, ***p < 0.001). Statistical analyses were performed using SPSS version